An encouraging paper on the use of PSMA PET prior to biopsy has just been published. PSMA-PET/CT shows potential with high diagnostic accuracy for clinically significant prostate cancer.
The PRIMARY Score: Using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis.
This is relevant to Telix because it would indicate the earlier and wider use of Illucix and higher profitability.
- Forums
- ASX - By Stock
- TLX
- The PRIMARY Score: PSMA PET/CT prostate cancer diagnosis.
The PRIMARY Score: PSMA PET/CT prostate cancer diagnosis.
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.85 |
Change
-0.650(3.51%) |
Mkt cap ! $5.973B |
Open | High | Low | Value | Volume |
$18.29 | $18.40 | $17.78 | $12.04M | 670.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 6515 | $17.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.88 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 6066 | 17.820 |
7 | 5922 | 17.800 |
2 | 1244 | 17.770 |
3 | 18235 | 17.760 |
5 | 2856 | 17.750 |
Price($) | Vol. | No. |
---|---|---|
17.880 | 200 | 1 |
17.930 | 4735 | 1 |
17.940 | 1244 | 2 |
17.960 | 4735 | 1 |
18.000 | 4735 | 1 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |